Survodutide
Survodutide
Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance. For laboratory research only. Not for human use.
Couldn't load pickup availability
Description
Survodutide
Survodutide is an investigational synthetic peptide and dual receptor agonist that activates both glucagon (GCGR) and GLP-1 (GLP-1R) receptors. It is designed to study the combined effects of these two signalling pathways, particularly their roles in metabolic regulation, energy balance and liver biology.
In laboratory and preclinical research, survodutide is investigated for its effects on glucose and lipid metabolism, energy expenditure and hepatic signalling. Research also examines its potential influence on pathways associated with fat accumulation and metabolic processes within the liver.
Survodutide is of interest in peptide pharmacology, metabolic research and liver biology, particularly for studying the interaction between GLP-1 and glucagon receptor signalling
Laboratory Research Data Analysis
- Synthetic peptide
- Dual GLP-1 and glucagon receptor agonis
- Targets GLP-1R and GCGR
- Studied in metabolic and liver research
- Investigated for effects on glucose and lipid metabolism
- Research includes energy-balance and metabolic signalling
- Studied in models of hepatic lipid metabolism
